Used in research and therapeutic development targeting inflammatory diseases and cancers where IL-8 signaling plays a key role. It neutralizes IL-8 activity, making it valuable for studying immune cell recruitment, angiogenesis, and tumor microenvironment modulation. Commonly applied in assays like ELISA, flow cytometry, and immunohistochemistry to detect or block IL-8. Investigated in preclinical models for conditions such as chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, and certain solid tumors. Supports the development of biologics aimed at suppressing excessive neutrophil activation and inflammation.